Navigation Links
WuXi PharmaTech Announces Third-Quarter 2010 Results
Date:11/9/2010

p>

34,415Accounts payable

16,065

14,356Accrued expenses

21,671

17,072Deferred revenue

7,192

4,554Advanced subsidies

2,630

2,800Other taxes payable

4,331

2,901Other current liabilities

6,609

4,239   Total current liabilities64,758

80,337Non-current liabilities:Long-term debt, excluding current portion

1,919

2,115Advanced subsidies

1,288

1,420Convertible notes

35,864

35,864Other non-current liabilities

6,567

7,432   Total non-current liabilities45,638

46,831   Total liabilities110,396

127,168Equity:Ordinary shares ($0.02 par value, 5,002,550,000 authorized as of September 30, 2010 and December 31, 2009, respectively; 559,232,416 and 550,609,256 issued and outstanding as of September 30, 2010 and December 31, 2009, respectively)

11,185

11,012Additional paid-in capital

329,193

320,672Accumulated earnings (deficit)

4,904

(68,631)Accumulated other comprehensive income

22,479

17,080   Total equity367,761

280,133 Total liabilities and equity478,157

407,301WUXI PHARMATECH (CAYMAN) INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands of U.S. dollars, except ADS data and per ADS data)Three Months EndedSeptember 30, Nine Months Ended September 30, 2010 2009 % Change 2010 2009% ChangeNet revenues:Laboratory Services

76,761

64,284

19%

216,340

182,369

19%Manufacturing Services

7,086

5,757

23%

29,146

13,774

112%Total net revenues83,847

70,041

20%

245,486

196,143

25%Cost of revenues:Laboratory Services

(48,152)

(36,731)

31%

(128,608)

(105,790)

22%Manufacturing Services

(5,865)

(4,540)

29%

(23,423)'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
2. WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call
3. Professor Steven V. Ley Speaks at WuXi PharmaTech
4. WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
5. WuXi PharmaTech Announces Second-Quarter 2010 Results
6. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
7. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
8. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
9. WuXi PharmaTech Announces First-Quarter 2010 Results
10. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
11. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC ... West Lafayette, Indiana , has enhanced its ... characterization of small and large molecules, including biologic ... the Bruker maXisPlus Q-TOF mass spectrometer. ... , CEO, Aptuit, said, "The expanded large molecule ...
(Date:8/21/2014)... Aug. 21, 2014   Memorial Hermann Health System ... today announced a new partnership to provide a new ... breast care centers in the greater Houston ... will become the exclusive provider of professional breast radiology services ... in Memorial City, The Woodlands , Northeast, ...
(Date:8/21/2014)... , Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic cancers and women,s health, has appointed Holly ... Managed Markets. Ms. Bauzon has a proven ... payer coverage for laboratory services companies. She has more ... PerkinElmer, Inc., where she held the position of Director, ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... I Results Offer Hope of First Highly Effective Drug in ... June 1 Roche announced today results from a Phase ... promising treatment for patients with advanced melanoma whose cancer harbours ... PLX4032 lived for a median of at least six months ...
... Eli Lilly and Company announced today that Phase ... (gemcitabine HCl for injection) to the current standard of ... at three years for women with locally advanced cervical ... commonly diagnosed women,s cancer, and the second most common ...
Cached Medicine Technology:Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 2Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 3Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 4Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6
(Date:8/21/2014)... (PRWEB) August 22, 2014 The ... NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray ... Forecast to 2018", analyzes and studies the major ... Europe, Asia, and the Rest of the World ... figures spread through 415 pages and in-depth TOC ...
(Date:8/21/2014)... 2014 Pack Expo is produced ... Processing Technologies. They deliver the industry’s best in ... whole new world of advancement and opportunity. You ... and the latest technology and innovations in processing, ... year at Pack Expo International, 50,000 attendees will ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Today, Zane ... information on the premium tax credits in 2015. , ... savings. As part of the Affordable Care Act (ACA), ... families purchase individual health insurance through the Health Insurance ... shows eligibility and the amount of the tax credits, ...
(Date:8/21/2014)... Arbor, Mich. Using heart-lung support technology, the University ... number of kidneys, livers and pancreases available for transplant ... in the journal Transplantation and detail the ... Membrane Oxygenation, or ECMO, to improve the quality and ... , "Organ transplant is limited by the number of ...
(Date:8/21/2014)... Md. (PRWEB) August 21, 2014 ... Houston with an Education Forum for PH patients ... , Who:    The Pulmonary Hypertension Association – ... to find ways to prevent and cure pulmonary ... that affects the functioning of the heart and ...
Breaking Medicine News(10 mins):Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:Extracorporeal support can significantly increase number of organs for transplant 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3
... and other health problems tend to accumulate and negatively affect ... issue of The Journal of Gerontology: Medical Sciences (Vol. 62A, ... of coexisting medical conditions - known as comorbidity - this ... topic. ,New diagnoses of common health problems add ...
... recent study finds that stents do not prevent heart ... minimize chest pains and to prevent heart attacks//. Stents ... keep them open. ,This landmark study funded ... stents do improve blood flow but are no more ...
... London- Green tea is popular for its abundant health ... placed on record// the benefits of a vital element ... The report has been published in the Journal of ... American and British researchers have discovered that an important ...
... increase in the number of licenses issued to foreign-trained ... 42 per cent of the 2,961 new licenses have ... ,Among the foreign-trained doctors who received licenses, only one-third ... enabled education licenses or positions for postgraduate training. ...
... welcomed the Federal Government’s decision to include the rotavirus vaccine ... the past year, the AMA has been calling for the ... most at risk of contracting the deadly disease, so we’re ... all Australian babies,” Dr Haikerwal said. ,“Rotavirus ...
... Bob Woolmer used a twisted towel to throttle him. //That ... newspaper reports from Jamaica, West Indies say. ... found unconscious in his hotel room in Jamaica, West Indies ... knocked out of the World Cup by debutants Ireland. He ...
Cached Medicine News:Health News:Stents Do Little to Prevent Heart Attacks 2Health News:Bob Woolmer Was Strangled With A Towel 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: